|Min SIP Amount||Not Supported|
|NAV||₹9.6 (19 Aug 2019)|
|Fund Started||27 Jul 2018|
|Fund Size||₹143 Cr|
|HDFC Bank Ltd.||Financial||Equity||7.3%|
|Glaxosmithkline Consumer Healthcare Ltd.||FMCG||Equity||5.7%|
|Aavas Financiers Ltd.||Financial||Equity||5.2%|
|Reliance Industries Ltd.||Energy||Equity||4.4%|
|Larsen & Toubro Ltd.||Construction||Equity||4.4%|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||3.6%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||3.6%|
|Ultratech Cement Ltd.||Construction||Equity||3.5%|
IDFC Equity Opportunity Series 6 Regular Growth is a Equity Mutual Fund Scheme launched by IDFC Mutual Fund. This scheme was introduced to investors on 27 Jul 2018. Anoop Bhaskar, Sumit Agrawal, Kartik Mehta is the Current Fund Manager of IDFC Equity Opportunity Series 6 Regular Growth.The fund currently has an Asset Under Management(AUM) of ₹143 Cr and the Latest NAV as of 19 Aug 2019 is ₹9.6.
The IDFC Equity Opportunity Series 6 Regular Growth is rated Moderately High risk. Minimum SIP Investment is 500. Minimum Lumpsum Investment is 5000. Nil.
1st Floor, Proms Complex, SBI
Colony, 1A Koramangala, 560034